Medistep Healthcare Ltd (MEDISTEP) — shareholding pattern, promoter holding, financials and share price
About Medistep Healthcare Ltd (MEDISTEP)
Medistep Healthcare Ltd operates in the Pharmaceuticals industry, within the Healthcare sector. It trades on the NSE as MEDISTEP and on the BSE under scrip code 94334. Its ISIN is INE0UOY01019.
Incorporated in June 2023, Medistep Healthcare Ltd manufactures and trades healthcare and personal care products. [1]
Listed peers in Pharmaceuticals: Sunrest Lifescience Ltd, Chandra Bhagat Pharma Ltd, Medicamen Organics Ltd, Gujarat Terce Laboratories Ltd, Venmax Drugs & Pharmaceuticals Ltd, Ishita Drugs & Industries Ltd.
Valuation & Returns
At ₹18.3 a share, Medistep Healthcare Ltd (MEDISTEP) was valued at a price-to-earnings ratio of 4.4x against an industry P/E of 36.41x and a price-to-book of 0.69x on a book value of ₹26.62 per share. Solomo computes return on equity of 15.82% and return on capital employed of 19.17% from filed results.
- P/E
- 4.4x
- Industry P/E
- 36.41x
- P/B
- 0.69x
- EPS (TTM)
- ₹4.01
- Book value / share
- ₹26.62
- ROE
- 15.82%
- ROCE
- 19.17%
- ROA
- 11.89%
- Debt / equity
- 0.14x
- Dividend yield
- 0%
- EBITDA margin
- 11.68%
- 52-week range
- ₹16.5 – ₹53
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Medistep Healthcare Ltd (MEDISTEP) reported revenue of ₹70.83 crore, net profit of ₹5.98 crore and earnings per share of ₹4.21. That compares with revenue of ₹49.65 crore and net profit of ₹4.14 crore in Mar 2025. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹35.76 crore and net profit ₹3.01 crore (standalone).
| Metric | Mar 2024 | Mar 2024 9m | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Revenue (₹ cr) | 31.62 | 31.6 | 49.65 | 70.83 |
| Net profit (₹ cr) | 2.91 | 2.91 | 4.14 | 5.98 |
| EPS (₹) | - | 5.94 | 3.96 | 4.21 |
| Measure | 1Y |
|---|---|
| Sales growth | 57.02% |
| Profit growth | 42.27% |
Ownership Summary
Mar 2026As of Mar 2026, promoters hold 68.96% of Medistep Healthcare Ltd (MEDISTEP). Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Sep 2025.
Largest disclosed public shareholders in Mar 2026: NITIN SINGH BHATI 4.69%, VIJITH NARAYANAN MENON 2.6%, TIRULEKHA BIOSCIENCES PRIVATE LIMITED 1.94%, BABITHA MENON 1.79%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Mar 2026 | 68.96% | - | - | - | - |
| Sep 2025 | 68.96% | - | - | - | - |